Research Article

Conifer Green Needle Complex in Patients with Precancerous Gastric Lesions: An Observational Pilot Study

Table 1

Characteristics of patients before treatment.

Parameters Group of patients
Treatment with CGNCControl

Number of patients ()2624
Women ()1918
Men ()76
Average age, years, mean ± standard deviation of the mean59.9 ± 2.460.7 ± 2.2
Symptoms of dyspepsia, (% of patients)26 (100%)24 (100%)
Endoscopic signs of atrophic gastritis, (% of patients)26 (100%)24 (100%)
Antrum: chronic atrophic gastritis, (% of patients)23 (88.5%)21 (87.5%)
Antrum and corpus chronic atrophic gastritis, (% of patients)3 (11.5%)3 (12.5%)
Gastric adenomatous polyps, (% of patients)7 (26.9%)7 (29.2%)
H. pylori infection, (% of patients)14 (53.8%)13 (54.2%)
Increased gastric juice pH, (% of patients)24 (92.3%)22 (91.7%)
Decreased pepsinogen-pepsin activity in gastric juice, (% of patients)23 (88.5%)22 (91.7%)
Decreased pepsinogen-pepsin activity in gastric mucosa, (% of patients)20 (76.9%)20 (83.3%)
Atrophy of gastric mucosa, (% of patients)
 All degrees26 (100%)24 (100%)
 Mild17 (65.4%)15 (62.5%)
 Moderate8 (30.8%)7 (29.2%)
 Severe1 (3.8%)2 (8.3%)
Intestinal metaplasia at histological and cytological examinations, (% of patients)
 All grades16 (61.5%)17 (70.8%)
 Degree 17 (43.7%)7 (41.2%)
 Degree 26 (37.5%)8 (47.1%)
 Degree 33 (18.7%)2 (11.8%)
Dysplasia3 (11.5%)3 (12.5%)
Lymphoplasmacytic infiltration at histological and cytological examination, (% of patients)
 All degrees26 (100%)24 (100%)
 Degree 112 (46.2%)12 (50%)
 Degree 26 (23.1%)3 (12.5%)
 Degree 38 (30.8%)9 (37.5%)